Trademark: 97682924
Status Date
Tuesday, April 2, 2024
Filing Date
Thursday, November 17, 2022
Published for Opposition
Tuesday, April 2, 2024
44 Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment
42 Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 2, 2024
Published For Opposition
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Feb 27, 2024
Approved For Pub - Principal Register
Feb 14, 2024
Teas/Email Correspondence Entered
Feb 14, 2024
Correspondence Received In Law Office
Feb 14, 2024
Teas Request For Reconsideration Received
Nov 24, 2023
Notification Of Final Refusal Emailed
Nov 24, 2023
Final Refusal E-Mailed
Nov 24, 2023
Final Refusal Written
Oct 25, 2023
Teas/Email Correspondence Entered
Oct 25, 2023
Correspondence Received In Law Office
Oct 25, 2023
Teas Response To Office Action Received
Jul 25, 2023
Notification Of Non-Final Action E-Mailed
Jul 25, 2023
Non-Final Action E-Mailed
Jul 25, 2023
Non-Final Action Written
Jul 18, 2023
Assigned To Examiner
Dec 8, 2022
New Application Office Supplied Data Entered
Nov 21, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
